Axogenesis Factor-1 (Alseres)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAxogenesis Factor-1 (Alseres)
Drug Alias NameAF-1 (Boston Life Sciences)CNS nerve growth factors (Boston Life Sciences)OncomodulinCNS nerve growth factors (Alseres)AF-1 (Alseres) +[7] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNerve growth factor receptors agonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsNerve DegenerationGlaucomaSpinal Cord Injuries +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoston Children'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoston Children'S HospitalAlseres Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNerve DegenerationGlaucomaSpinal Cord Injuries +[4] 

Other Information

ATC CodeN/A
Related LinksN/A